HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henrik H Hansen Selected Research

Amylin Receptor Agonists

4/2021Whole-brain mapping of amylin-induced neuronal activity in receptor activity-modifying protein 1/3 knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henrik H Hansen Research Topics

Disease

12Obesity
01/2022 - 06/2010
10Body Weight (Weight, Body)
01/2022 - 06/2010
9Schizophrenia (Dementia Praecox)
03/2020 - 06/2007
8Weight Loss (Weight Reduction)
01/2022 - 06/2010
7AIDS-Related Complex (ARC)
11/2019 - 05/2007
6Fibrosis (Cirrhosis)
01/2022 - 11/2017
6Inflammation (Inflammations)
01/2021 - 01/2018
6Alzheimer Disease (Alzheimer's Disease)
03/2020 - 01/2010
4Non-alcoholic Fatty Liver Disease
01/2022 - 11/2017
4Alcoholic Fatty Liver
01/2022 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2014
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 01/2003
3Parkinson Disease (Parkinson's Disease)
11/2019 - 01/2016
3Fatty Liver
01/2019 - 01/2018
2Amyloid Plaque
01/2016 - 01/2015
1Metabolic Diseases (Metabolic Disease)
04/2021
1Albuminuria
01/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2021
1Hyperglycemia
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Hypertrophy
01/2021
1Infarction (Infarctions)
01/2021
1Kidney Diseases (Kidney Disease)
01/2021
1Myocardial Infarction
01/2021
1Mental Disorders (Mental Disorder)
03/2020
1Gliosis
11/2019
1Intestinal Diseases (Diseases, Intestinal)
10/2019
1Hepatomegaly
01/2019
1Parkinsonian Disorders (Parkinsonism)
01/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2016
1Contusions
06/2016
1Brain Injuries (Brain Injury)
06/2016
1Tauopathies
03/2016

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
01/2021 - 06/2007
7Messenger RNA (mRNA)IBA
01/2018 - 05/2007
6Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2020 - 05/2007
6Glucagon-Like Peptide 1 (GLP 1)IBA
10/2019 - 10/2014
6LiraglutideFDA Link
01/2018 - 10/2014
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2018
4Peptides (Polypeptides)IBA
01/2021 - 01/2016
4Proteins (Proteins, Gene)FDA Link
06/2016 - 05/2007
4TesofensineIBA
09/2013 - 06/2010
3LipidsIBA
01/2022 - 06/2010
3CollagenIBA
07/2020 - 01/2018
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2019 - 04/2002
3Biomarkers (Surrogate Marker)IBA
06/2016 - 02/2010
3Amyloid (Amyloid Fibrils)IBA
03/2016 - 01/2015
3SSR180711IBA
12/2010 - 05/2007
3ParvalbuminsIBA
12/2010 - 05/2009
2nasIBA
01/2022 - 01/2018
2Islet Amyloid PolypeptideIBA
04/2021 - 09/2019
2LinagliptinIBA
01/2021 - 10/2014
2Insulin (Novolin)FDA Link
01/2021 - 10/2005
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2021 - 10/2014
2RNA (Ribonucleic Acid)IBA
11/2019 - 01/2019
2salicylhydroxamic acid (SHAM)IBA
11/2019 - 04/2016
2Appetite Depressants (Anorectics)IBA
01/2019 - 10/2014
22- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA
01/2019 - 01/2018
2Oxidopamine (6 Hydroxydopamine)IBA
01/2017 - 01/2016
2Glucagon-Like Peptide-1 ReceptorIBA
03/2016 - 01/2015
2Dopamine (Intropin)FDA LinkGeneric
09/2013 - 04/2002
2ezogabine (retigabine)IBA
02/2012 - 01/2011
2SynaptophysinIBA
12/2010 - 05/2009
2Phencyclidine (Angel Dust)IBA
12/2010 - 01/2010
2N-Methylaspartate (NMDA)IBA
01/2010 - 10/2005
2EndocannabinoidsIBA
01/2003 - 04/2002
1Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA
01/2022
1lanifibranorIBA
01/2022
1semaglutideIBA
01/2022
1Hormones (Hormone)IBA
04/2021
1Amylin Receptor AgonistsIBA
04/2021
1LectinsIBA
01/2021
1empagliflozinIBA
01/2021
1Rosiglitazone (Avandia)FDA Link
01/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021
1Captopril (Capoten)FDA LinkGeneric
01/2021
1Lisinopril (Prinivil)FDA LinkGeneric
01/2021
1Therapeutic UsesIBA
01/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2019
1NeuropeptidesIBA
11/2019
1Peptide Hormones (Polypeptide Hormones)IBA
10/2019
1Glucagon (Glukagon)FDA Link
10/2019
1CholesterolIBA
10/2019
1Glucagon-Like Peptide-2 ReceptorIBA
10/2019
1Dietary Fats (Dietary Fat)IBA
09/2019
1LeptinIBA
09/2019
1CDAA (Randox)IBA
01/2019
1Galectin 3 (LGALS3)IBA
01/2018
16-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA
01/2018
1obeticholic acidIBA
01/2018
1uroguanylinIBA
01/2018
1guanylinIBA
01/2018

Therapy/Procedure

4Therapeutics
01/2022 - 10/2005
4Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2021 - 10/2012
3Drug Therapy (Chemotherapy)
01/2021 - 11/2017
2Glycemic Control
01/2018 - 06/2010
2Obesity Management
09/2013 - 06/2010
1Diet Therapy (Therapy, Diet)
11/2019
1Lasers (Laser)
11/2019